Niku Singh
Psychiatry · Falls Church, VANPI 1558374595
Payments from drug & device makers
Across 3,556 payments — averaging $692.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$919K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$594K
- Axsome Therapeutics, Inc.$318K
- Otsuka America Pharmaceutical, Inc.$296K
- Alkermes, Inc.$143K
- E.r. Squibb & Sons, L.L.C.$120K
- plus $74K from 23 others
What the payments were for
- Consulting fees$182,0127%
- Speaking & faculty fees$1,762,38572%
- Travel & lodging$451,39718%
- Food & beverage$67,6923%
- Education$2440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 1,112 | $918,752 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 640 | $593,560 |
| Axsome Therapeutics, Inc. | 345 | $317,587 |
| Otsuka America Pharmaceutical, Inc. | 453 | $296,360 |
| Alkermes, Inc. | 182 | $143,352 |
| E.r. Squibb & Sons, L.L.C. | 132 | $120,273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 106 | $42,981 |
| Eisai Inc. | 36 | $17,719 |
| Ironshore Pharmaceuticals Inc. | 117 | $2,860 |
| Lundbeck LLC | 78 | $1,625 |
| Vanda Pharmaceuticals Inc. | 72 | $1,568 |
| Bausch Health US, LLC | 76 | $1,414 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 16 | $1,321 |
| Sunovion Pharmaceuticals Inc. | 18 | $1,175 |
| Collegium Pharmaceutical, Inc. | 30 | $678 |
| Neos Therapeutics, LP | 42 | $585 |
| Supernus Pharmaceuticals, Inc. | 39 | $436 |
| Johnson & Johnson | 11 | $376 |
| Corium, LLC | 4 | $349 |
| Avanir Pharmaceuticals, Inc. | 21 | $219 |
| Shire North American Group Inc | 9 | $157 |
| Merck | 9 | $155 |
| Sage Therapeutics, LLC | 1 | $87 |
| Adlon Therapeutics L.p. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Aytu Biopharma, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,463,731 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 13 | $13,672 |
| BelsomraSuvorexant | 20 | $10,512 |
| TrintellixVortioxetine Hydrobromide | 11 | $7,053 |
| Duloxetine Hcl | 47 | $1,763 |
| Quetiapine Fumarate | 64 | $1,272 |
| Bupropion XlBupropion Hcl | 25 | $721 |
| Clonazepam | 33 | $614 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 29 | $595 |
| Clozapine | 12 | $478 |
| Aripiprazole | 26 | $411 |
| Gabapentin | 17 | $378 |
| Trazodone Hcl | 26 | $374 |
| Lorazepam | 15 | $365 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $359 |
| Olanzapine | 11 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $155 | $10,51220 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $42,981 | $7,05311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 884 psychiatry providers in Virginia.
Other psychiatry in Falls Church
- Husam AlathariFalls Church$48K
- Michael ClarkFalls Church$18K
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- Jasdeep MiglaniManassas$958K
- Frederick MoellerRichmond$678K
- David SpiegelNorfolk$565K
- Christopher van EyckStafford$392K
- Anita ClaytonCharlottesville$356K
- Anita KablingerRoanoke$333K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.